Usage des psychotropes et troubles psychiatriques en France : résultats de l’étude épidémiologique ESEMeD/MHEDEA 2000/ (ESEMeD) en population générale

L'Encéphale - Tập 31 Số 2 - Trang 195-206 - 2005
I. Gasquet1, Laurence Nègre‐Pagès2, A Fourrier3, Gaëlle Nachbaur4, Abdelkader El-Hasnaoui4, V. Kovess5, Jean-Pierre Lépine6
1INSERM U669, Maison des adolescents, 97, boulevard de Port-Royal, 75679 Paris cedex 14, France. Direction de la Politique Médicale (DAM), Assistance Publique - Hôpitaux de Paris, Paris
2Pharmacologie, Faculté de médecine, Toulouse, France
3EA3676, MPSS, Pharmacologie, Université Victor Segalen, Bordeaux, France
4GlaxoSmithKline, Marly le Roi, France.
5Fondation MGEN pour la Santé Publique, Paris, France
6INSERM U705, CNRS, UMR 7157, Universités Paris 5 et 7 Hôpital Fernand Widal, AP-HP, 200, rue du Faubourg Saint-Denis, 75475 Paris cedex 10, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Amar E. Les dépenses de médicaments remboursables en 2002. In. Paris: DRESS (ministère de la santé); 2003 : 1-8. Adresse Internet : http://sante.gouv.fr, rubrique : Recherche, Études et Statistiques

Afssaps. Analyse des ventes de médicaments aux officines et aux hôpitaux en France, 1998-2000 2002 ; 1-93, téléchargeable sur le site de l’AFSSAPS : http://agmed.sante.gouv.fr/pdf/5/med2004.pdf

Balsan D, Chambaretaud S. La croissance des dépenses de médicaments remboursables entre 1998 et 2001. Études et résultats, Direction de la recherche des études de l’évaluation et des statistiques (ministère de l’emploi et de la solidarité) 2002 ; 166 : 1-8. Adresse Internet: http://sante.gouv.fr, rubrique : Recherche, Études et Statistiques

Baumann, 2002, Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration, Encephale, 28, 389

Beardsley, 1998, Prescribing of psychotropic medication by primary care physicians and psychiatrists, Arch Gen Psychiatry, 45, 1117, 10.1001/archpsyc.1988.01800360065009

Bebbington, 1995, The epidemiology of bipolar affective disorder, Soc Psychiatry Psychiatr Epidemiol, 30, 279, 10.1007/BF00805795

Bouhassira, 1998, Which patients receive antidepressants ? A ‘real world’ telephone study, J Affect Disord, 49, 19, 10.1016/S0165-0327(97)00193-6

Browne, 1998, Issues to consider when conducting research using physician-reported antidepressant claims, Drug Benet Trends, 10, 37

Dimatteo, 2000, Depression is a risk factor for non-compliance with medical treatment : meta-analysis of the effects of anxiety and depression on patient adherence, Arch Intern Med, 160, 2101, 10.1001/archinte.160.14.2101

Druss, 2000, Underuse of antidepressants in major depression : prevalence and correlates in a national sample of young adults, J Clin Psychiatry, 61, 238, 10.4088/JCP.v61n0315

Dunn, 1999, Longitudinal patterns of antidepressant prescribing in primary care in the UK : comparison with treatment guidelines, J Psychopharmacol, 13, 136, 10.1177/026988119901300204

2004, Prevalence of mental disorders in Europe : results from the European Study of Epidemiology of Mental Disorders (ESEMe D/MHEDEA 2000) project, Acta Psychiatr Scand, 109, 21

2004, Sampling and methods of the European Study of Epidemiology of Mental Disorders (ESEMe D/MHEDEA 2000) project, Acta Psychiatr Scand, 109, 8

2004, Psychotropic drug utilization in Europe : results from the European Study of the Epidemiology of Mental Disorders (ESEMe D/MHEDEA 2000) project, Acta Psychiatr Scand, 109, 55

Gasquet, 2001, Determinants of compliance with antidepressive drugs, Encephale, 27, 83

Guelfi, 1998, Are too many antidepressants being prescribed in France ?, Presse Med, 27, 2126

Guignon N, Morniche P, Sermet C. La consommation régulière de psychotropes. Rapport INSEE n°310, avril 1994.

Katz, 1998, Medication management of depression in the United States and Ontario, J Gene Intern Med, 13, 77, 10.1046/j.1525-1497.1998.00022.x

Kessler, 2004, The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI), Int J Methods Psychiatr Res, 13, 93, 10.1002/mpr.168

Kessler, 1999, Past year use of outpatient service for psychiatric problems in the National Comorbidity Survey, Am J Psychiatry, 156, 115, 10.1176/ajp.156.1.115

Lagnaoui, 2004, Patterns and correlates of benzodiazepine use in the French general population, Eur J Clin Pharmacol, 60, 523, 10.1007/s00228-004-0808-2

Lapeyre-mestre, 1999, Drug consumption in workers in France : a comparative study at a10-year interval (1996 versus 1986), J Clin Epidemiol, 52, 471, 10.1016/S0895-4356(99)00008-6

Laukkala, 2001, Antidepressant treatment of depression in the Finnish general population, Am J Psychiatry, 158, 2077, 10.1176/appi.ajp.158.12.2077

Lecadet, 2003, Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine. I. Données nationales, 2000, Rev Med Assu Mal, 34, 75

Lecadet, 2003, Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine. II Données et comparaisons régionales, 2000, Rev Med Assu Mal, 34, 233

Lecomte, 1992

Leger, 2000, Prevalence of insomnia in a survey of 12,778 adults in France, J Sleep Res, 9, 35, 10.1046/j.1365-2869.2000.00178.x

Lépine, 1997, First pan-european study of depression in the community : Depression Research in European Society, Intern Clinical Psychopharmacol, 12, 19, 10.1097/00004850-199701000-00003

Lépine, 2005, Prévalence et comorbidité des troubles psychiatriques dans la population générale française : résultats de l’étude épidémiologique ESEMe D/MHEDEA 2000/(ESEMe D), Encephale, 30, 182, 10.1016/S0013-7006(05)82385-1

Morabia, 1992, The influence of patient and physician gender on prescription of psychotropic drugs, J Clin Epidemiol, 45, 111, 10.1016/0895-4356(92)90003-6

Mueser, 2004, Schizophrenia, Lancet, 363, 2063, 10.1016/S0140-6736(04)16458-1

Ohayon, 2002, Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom, J Clin Psychiatry, 63, 817, 10.4088/JCP.v63n0912

Olie, 2002, Antidepressant consumption in the global population in France, Encephale, 28, 411

Olfson, 2002, National trends in the outpatient treatment of depression, JAMA, 287, 203, 10.1001/jama.287.2.203

Pariente, 1992, Self-reported psychotropic drug use and associated factors in a French community sample, Psychol Med, 22, 181, 10.1017/S0033291700032839

Pelissolo, 1996, Epidémiologie de la consommation des anxiolytiques et des hypnotiques en France et dans le monde, Encephale, 22, 187

Regier, 1991, The stability of mental disorder prevalence data from the NIMH ECA program, Presented at the Annual Meeting of the American Psychiatric Association

Rouillon, 1996, Pharmaco-epidemiologic study of the use of antidepressant drugs in the general population, Encephale, 39

Spijker, 2001, Care utilization and outcome of DSM III-R major depression in the general population Results from the Netherlands Mental Health Survey and Incidence study (NEMESIS), Acta Psychiatr Scand, 104, 19, 10.1034/j.1600-0447.2001.00363.x

Tylee, 1999, Depres II. A patient survey of the symptoms, disability and current management of depression in the community, Int Clin Psychopharmacol, 14, 139

Wells, 1994, Use of minor tranquilizer and antidepressant medications by depressed outpatients : results from the medical outcomes study, Am J Psychiatry, 151, 694, 10.1176/ajp.151.5.694

Zito, 2001, Services and prevention : pharmacoepidemiology of antidepressant use, Biol Psychiatry, 49, 1121, 10.1016/S0006-3223(01)01174-X